drugset / Trial / NCT00706836

PharmacofMRI of Anxiolytic Medications (Pregabalin)

NCT00706836

RandomizedCrossoverSingle-blindDiagnostic

Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function. In this case, the medication pregabalin will be used. The investigators hypothesize that pregabalin (at doses of 50 mg and 200 mg, versus placebo) will yield a reduction in amygdala and insula activity (in a dose-dependent fashion) during emotion processing using fMRI.

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 50 mg Oral
Comparator Pregabalin Small molecule 200 mg Oral

Indications